• Exelixis signs drug licensing deal with Aurigene pharmaceutical-technology
    August 02, 2019
    US-based biotechnology company Exelixis has signed an exclusive collaboration, option and license agreement with India-based Aurigene Discovery Technologies for discovery and development of new oncology treatments.
PharmaSources Customer Service